Brain cancer breakthrough? laser, electric fields, and drug combo tested
NCT ID NCT06558214
Summary
This study is testing the safety and feasibility of a three-part treatment for adults whose aggressive brain cancer (glioblastoma) has returned. The treatment combines a wearable device that uses electric fields to disrupt cancer cells, a precise laser surgery to destroy the tumor, and an immunotherapy drug (pembrolizumab) to help the immune system fight the cancer. The main goals are to see if this combination is safe and can be successfully delivered to patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UF Health Shands Hospital
RECRUITINGGainesville, Florida, 32608, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.